Contents
Fighting Back: Cutting-Edge Treatments for Acquired Hemophilia A
Published: Apr 04, 2024
Treating acquired hemophilia A is like waging a two-front war. Doctors must simultaneously stop dangerous bleeding and eliminate the rogue antibodies causing the problem. Let's explore the arsenal of treatments available to combat this rare but serious condition.
Stopping the Bleeding
The first priority is controlling acute bleeding, which can be life-threatening. Bypassing agents are the heavy artillery in this fight. These include recombinant activated factor VII (rFVIIa) and activated prothrombin complex concentrates (aPCC). They work by activating clotting through pathways that bypass the missing factor VIII. In some cases, especially with lower inhibitor levels, human factor VIII concentrates might be used.
Eliminating the Inhibitor
The long-term strategy involves suppressing or eliminating the inhibitor. This typically starts with immunosuppressive therapy. Corticosteroids like prednisone are often the first line of attack. For tougher cases, doctors may add cyclophosphamide or other immunosuppressants. A newer weapon in the arsenal is rituximab, a monoclonal antibody that targets B cells responsible for producing the inhibitor.
Emerging Therapies
Research is ongoing to develop new treatments. One exciting option is emicizumab, a bispecific antibody that mimics the function of factor VIII. While primarily used in inherited hemophilia A, it's showing promise in acquired cases too. Another innovative approach involves using immunoadsorption to physically remove the inhibitors from the blood.
Supportive Care
Treatment isn't just about medications. Patients often need supportive care, including careful monitoring, pain management, and sometimes blood transfusions. Physical therapy may be necessary to regain strength and mobility after severe bleeding episodes. Psychological support is also crucial, as the condition can be emotionally challenging for patients.
Frequently Asked Questions
Bleeding control can be rapid, but eliminating inhibitors may take weeks to months.
Many patients achieve remission, but some may need ongoing care.
Immunosuppressive treatments can have significant side effects, requiring careful monitoring.
Some can, but initial treatment often requires hospitalization.
It varies, but can range from weeks to months or longer.
Hope on the Horizon
While acquired hemophilia A remains a challenging condition, advances in treatment are offering new hope and improved outcomes for patients.
References
- Kruse-Jarres R, et al. Acquired hemophilia A: Updated review of evidence and treatment guidance. Am J Hematol. 2017;92(7):695-705.
- Tiede A, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020;105(7):1791-1801.
- Knoebl P, et al. Emicizumab for the treatment of acquired hemophilia A. Blood. 2021;137(3):410-419.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
Top licensed doctors
Available in all 50 states
Full service care
Prescriptions, referrals & treatment
No insurance needed
All notes available in Doctronic
15-min consultation. No hidden costs.
AI Doctor Visit Required
Please Chat With Our AI Doctor First
Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?